Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
23.44
0.00 (0.00%)
May 21, 2026, 9:52 AM EDT - Market open
Assertio Holdings Revenue
Assertio Holdings had revenue of $9.93M in the quarter ending March 31, 2026, a decrease of -62.50%. This brings the company's revenue in the last twelve months to $102.16M, down -14.16% year-over-year. In the year 2025, Assertio Holdings had annual revenue of $118.71M, down -5.00%.
Revenue (ttm)
$102.16M
Revenue Growth
-14.16%
P/S Ratio
1.48
Revenue / Employee
$1,927,509
Employees
53
Market Cap
151.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 118.71M | -6.25M | -5.00% |
| Dec 31, 2024 | 124.96M | -27.11M | -17.83% |
| Dec 31, 2023 | 152.07M | -4.17M | -2.67% |
| Dec 31, 2022 | 156.23M | 45.22M | 40.73% |
| Dec 31, 2021 | 111.01M | 4.74M | 4.46% |
| Dec 31, 2020 | 106.28M | -123.23M | -53.69% |
| Dec 31, 2019 | 229.50M | -82.27M | -26.39% |
| Dec 31, 2018 | 311.77M | -68.95M | -18.11% |
| Dec 31, 2017 | 380.72M | -75.17M | -16.49% |
| Dec 31, 2016 | 455.90M | 113.16M | 33.02% |
| Dec 31, 2015 | 342.74M | -47.63M | -12.20% |
| Dec 31, 2014 | 390.36M | 256.16M | 190.87% |
| Dec 31, 2013 | 134.21M | 43.39M | 47.78% |
| Dec 31, 2012 | 90.82M | -42.16M | -31.70% |
| Dec 31, 2011 | 132.97M | 52.21M | 64.64% |
| Dec 31, 2010 | 80.76M | 23.04M | 39.90% |
| Dec 31, 2009 | 57.73M | 22.89M | 65.69% |
| Dec 31, 2008 | 34.84M | -30.74M | -46.87% |
| Dec 31, 2007 | 65.58M | 56.03M | 586.65% |
| Dec 31, 2006 | 9.55M | 5.15M | 116.82% |
| Dec 31, 2005 | 4.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 232.40M |
| Organigram Global | 196.43M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 116.26M |
| SIGA Technologies | 93.78M |
| Journey Medical | 64.68M |
| Cumberland Pharmaceuticals | 41.94M |
ASRT News
- 7 days ago - Assertio to be acquired by Zydus Worldwide DMCC for $23.50 per share - TheFly
- 7 days ago - Assertio price target raised to $23.50 from $21.80 at Lake Street - TheFly
- 8 days ago - Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash - Business Wire
- 12 days ago - Assertio, Garda agree to delay launch of tender offer - TheFly
- 13 days ago - Assertio and Garda Mutually Agree to Delay Launch of Tender Offer - Business Wire
- 13 days ago - Assertio Holdings Quarterly report: Q1 2026 - Filings
- 16 days ago - Assertio, Garda agree to postpone commencement of tender offer - TheFly
- 16 days ago - Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer - Business Wire